FREE LIVE WEBINAR WITH Q&A
Wednesday, August 25, 2021 | 1-2 pm EDT
Novel testing approaches enable clinical labs to advance and expand their UTI testing capabilities
David Baunoch, PhD
David Baunoch received his PhD in microbiology and molecular genetics from Wayne State University and completed an NIH Postdoctoral Fellowship in Breast Cancer Research at the Michigan Cancer Foundation. Dr. Baunoch has more than 25 years of laboratory experience in a number of areas and has produced over 25 peer-reviewed publications. Before founding Pathnostics, he held a variety of executive management positions with industry-leading companies, including Ventana Medical Systems and US LABS, and was founder and president of Combimatrix Molecular Diagnostics.
Jorge Fonseca, MBA
Product Director, Genetic Testing Solutions, Genetic Sciences Division
Thermo Fisher Scientific
Jorge Fonseca holds a degree in Mechanical Engineering from the Massachusetts Institute of Technology and an MBA from the University of Massachusetts Amherst. He has 18 years of experience in the life sciences industry. Jorge started his career in R&D, where he was involved in the development of various qPCR-based products. Since transitioning to product management, he has held a number of roles with global ownership of product lines covering research, agrigenomics, and clinical applications. Currently, he leads a team responsible for a portfolio of molecular testing solutions spanning qPCR, capillary electrophoresis, and microarray technologies.
By attending Advancements in UTI Testing: A Multi-omics Approach to Maximizing the Flexibility of Your Molecular Testing Laboratory, you and your team will:
- Understand the impact of urinary tract infections (UTIs) in patient care.
- Evaluate the technical challenges and limitations associated with urine culture.
- Explain the roles of the urinary microbiome and polymicrobial infections in the management of UTIs.
- Compare the clinical utility of genotypic and phenotypic methods in treatment of UTIs.
- Describe how a multi-omics approach could be implemented in a laboratory.
- Learn how to implement molecular testing services or expand your existing menu.
- Evolve content, formats, and throughput within a single platform for the most common disease areas including respiratory, urinary tract, and vaginal pathogen detection.
- Explore controls and analytical validation service options needed for implementation.
Who should attend?
- Clinical laboratory directors
- Laboratory managers
- Clinical pathologists
- Laboratory technicians
- Academic medical centers
- Public health laboratories
- Anyone involved in clinical laboratory testing
Your registration includes:
- The opportunity to pose specific questions and connect directly with speakers during a Q&A session
- Access to the post-webinar recording